GlaxoSmithKline plc (GSK) Receives FDA Approval of Arnuity Ellipta as Asthma Maintenance Treatment
Tweet Send to a Friend
GlaxoSmithKline plc (NYSE: GSK) announced that the FDA has approved Arnuity Ellipta (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
